Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Crescent Capital BDCCCAP -1.20%43 3-Year EPS without NRI Growth Rate is 23.00% as of Jun. 2026, which is at its 10-year median of 23.00. GuruFocus rates CCAP with a GF Score™ of 43/100 and a GF Value™ of $1.79 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 831 Asset Management companies, Crescent Capital BDC ranks better than 62.45% on this metric.
During the past 12 months, Crescent Capital BDC's average EPS without NRI Growth Rate was -107.50% per year.
During the past 3 years, the average EPS without NRI Growth Rate was 23.00% per year.
During the past 5 years, the average EPS without NRI Growth Rate was -9.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 10 years, the highest 3-Year average EPS without NRI Growth Rate of Crescent Capital BDC was 120.30% per year. The lowest was -20.10% per year. And the median was 23.00% per year.
Crescent Capital BDC (NAS:CCAP) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Crescent Capital BDC 3-Year EPS without NRI Growth Rate Related Terms
CCAP vs VKI, HFRO, SDHY: 3-Year EPS without NRI Growth Rate Comparison
For the Asset Management subindustry, Crescent Capital BDC's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Crescent Capital BDC 3-Year EPS without NRI Growth Rate vs Asset Management Industry
For the Asset Management industry and Financial Services sector, Crescent Capital BDC's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Crescent Capital BDC's 3-Year EPS without NRI Growth Rate falls into.
Crescent Capital BDC 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 23.00% mean?
Crescent Capital BDC (CCAP) has a 3-Year EPS without NRI Growth Rate of 23.00% as of Jun. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Crescent Capital BDC and its competitors. This is near median its historical median of 23.00. According to the industry distribution chart, Crescent Capital BDC ranks #312 out of 831 companies in the Asset Management industry, placing it in the top 37.5%.
Is Crescent Capital BDC's 3-Year EPS without NRI Growth Rate too high?
Crescent Capital BDC's current 3-Year EPS without NRI Growth Rate of 23.00% is near median its 10-year median of 23.00. The Asset Management industry median 3-Year EPS without NRI Growth Rate is 11.70. Crescent Capital BDC's value of 23.00% is 96.6% above this industry median. Based on the distribution chart, Crescent Capital BDC ranks #312 out of 831 companies in the Asset Management industry, which is above the industry midpoint. Overall, Crescent Capital BDC has a GF Score™ of 43/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Crescent Capital BDC's 3-Year EPS without NRI Growth Rate compare to VKI and HFRO?
According to the Asset Management industry distribution chart, Crescent Capital BDC ranks #312 out of 831 companies for 3-Year EPS without NRI Growth Rate. This puts Crescent Capital BDC in the upper half of its industry. The industry median 3-Year EPS without NRI Growth Rate is 11.70. Crescent Capital BDC's value of 23.00% is 96.6% above this benchmark. While the company's 10-year median is 23.00 vs. the industry median of 11.70, Crescent Capital BDC has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for an Asset Management company?
The median 3-Year EPS without NRI Growth Rate among Asset Management companies is 11.70, based on 831 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Crescent Capital BDC's current 3-Year EPS without NRI Growth Rate of 23.00% is 96.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Crescent Capital BDC and its competitors. For the Asset Management industry, the median 3-Year EPS without NRI Growth Rate is 11.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Crescent Capital BDC's current 3-Year EPS without NRI Growth Rate is 23.00%, which is near median its own 10-year median of 23.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Crescent Capital BDC stock overvalued right now?
Based on GuruFocus' analysis, Crescent Capital BDC (CCAP) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.79, compared to a current price of $10.68 — trading 496.6% above its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 23.00%, which is near median its 10-year median of 23.00 and 96.6% above the Asset Management industry median of 11.70. Crescent Capital BDC's overall GF Score™ is 43/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For Crescent Capital BDC (CCAP), the current 3-Year EPS without NRI Growth Rate is 23.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Crescent Capital BDC (CCAP) Overvalued in 2026?
Based on GuruFocus' analysis, Crescent Capital BDC stock appears to be overvalued.
The current stock price of $10.68 is trading 496.6% above its estimated GF Value™ of $1.79.
GuruFocus considers Crescent Capital BDC to be Significantly Overvalued.
Key valuation signals for CCAP:
3-Year EPS without NRI Growth Rate: 23.00% (near median its 10-year median of 23.00)
GF Value™: $1.79 vs. price of $10.68 (496.6% above fair value)
Industry Position: 96.6% above the Asset Management median (#312 of 831)
No single metric tells the full story. See the CCAP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Crescent Capital BDC Inc is a business development company structured as an externally managed, closed-end, non-diversified management investment company. The company's primary investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It will seek to achieve its investment objectives by investing in secured debt (including senior secured, unitranche, and second lien debt) and unsecured debt (including senior unsecured, mezzanine, and subordinated debt), as well as related equity securities of private U.S. middle-market companies.
43GF Score
Get the complete analysis for CCAP
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CCAP has been successfully added to your 
